/ NVO
/ Market Analysis
Why Is Hims & Hers (HIMS) Stock Soaring Premarket Today? Novo Nordisk Deal Report
Hims & Hers stock surged over 44% in premarket trading after a report said Novo Nordisk plans to sell its obesity drugs through the company’s telehealth ...
March 09, 2026
Why Is Novo Nordisk Stock Down 13% Premarket? Trial Fails to Match Eli Lilly
Novo Nordisk stock plunged over 13% in premarket trading after its experimental obesity drug CagriSema failed to prove non-inferiority to Eli Lilly's tirzepatide in the REDEFINE 4 trial.
February 23, 2026
Novo Nordisk Shares Rise After FDA Pressures Hims to Pull Weight-Loss Pill
Novo Nordisk stock jumped 8% after Hims & Hers withdrew its knockoff Wegovy pill amid FDA scrutiny and legal threats.
February 09, 2026
Novo Nordisk (NVO) Shares Fall on Unexpected 2026 Sales Outlook
Novo Nordisk shares tumbled 18% after the company issued unexpectedly weak 2026 guidance, forecasting sales could decline as much as 13%.
February 04, 2026
Why Is Novo Nordisk (NVO) Stock Up Today? Wegovy Pill Demand Looks Strong
Novo Nordisk stock moved higher after oral Wegovy logged over 18,000 first-week prescriptions, with Goldman Sachs boosting sentiment via a Buy rating.
January 23, 2026More from The Tokenist / NVO
Why Did Novo Nordisk (NVO) Stock Jump in Premarket Today?
November 10, 2025
Back to 
